Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04059952 · ClinicalTrials.gov registry record
Mechanism of Action of Electroconvulsive Therapy
A clinical trial of Bipolar Depression and Unipolar Depression, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 102
- Enrollment target
- 1
- Study location
NCT04059952: Completed study of Bipolar Depression and Unipolar Depression, sponsored by Massachusetts General Hospital.
NCT04059952 is a study of Bipolar Depression and Unipolar Depression that has completed, run by Massachusetts General Hospital. The registered enrollment target is 102 participants, below the 213-participant average among 29 other Bipolar Depression trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04059952, a study of Bipolar Depression and Unipolar Depression, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational neuroimaging study assessing the effects of ECT on the brains of patients with unipolar and bipolar depression.
Conditions Studied
Interventions
- DEVICE Electroconvulsive Therapy
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2019-06-28 |
| Est. Completion | 2024-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04059952
The ClinicalTrials.gov registry entry for NCT04059952 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 213-participant average among 29 other Bipolar Depression trials with a reported enrollment target (52% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bipolar Depression appearing as the primary indexed condition, and to 1 intervention - of which Electroconvulsive Therapy is the first listed.
NCT04059952 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04059952 about?
NCT04059952 is a clinical study titled "Mechanism of Action of Electroconvulsive Therapy". This is an observational neuroimaging study assessing the effects of ECT on the brains of patients with unipolar and bipolar depression.
What is the current status of trial NCT04059952?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2019-06-28. Estimated completion is 2024-05-31.
What conditions does trial NCT04059952 study?
This clinical trial studies the following conditions: Bipolar Depression, Unipolar Depression.
What interventions are being tested in trial NCT04059952?
The interventions under investigation include: Electroconvulsive Therapy (DEVICE).
Who is sponsoring clinical trial NCT04059952?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04059952 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
RECRUITING · Early Phase 1
-
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
RECRUITING · Phase 3
-
University of Iowa Interventional Psychiatry Service Patient Registry
RECRUITING
-
Ketogenic Intervention for Bipolar Depression
RECRUITING · NA
-
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
RECRUITING · Phase 4
-
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
RECRUITING · Phase 3
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.